Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mark Richards

Showing results (171-180 of 390) with videos related to

Pageof 39
Sort By:
Frontiers in Cardiovascular Medicine|December 11, 2020
Systemic Mesenchymal Stem Cell-Derived Exosomes Reduce Myocardial Infarct Size: Characterization With MRI in a Porcine ModelChristopher J Charles, Renee R Li, Teresa Yeung, et al.
Chest|November 2, 2013
OSA and coronary plaque characteristicsAdeline Tan, William Hau, Hee-Hwa Ho, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 8, 2010
New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosisAaron L Baggish, Roland R J van Kimmenade, Yigal Pinto, et al.
Journal of the American College of Cardiology|February 2, 2010
N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trialJohn G Lainchbury, Richard W Troughton, Kim M Strangman, et al.
Journal of Cardiac Failure|July 31, 2010
Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failureW H Wilson Tang, Kevin Shrestha, Maureen G Martin, et al.
The American Journal of Emergency Medicine|May 25, 2013
Validation of the Vancouver Chest Pain Rule using troponin as the only biomarker: a prospective cohort studyJaimi H Greenslade, Louise Cullen, Martin Than, et al.
Clinical Chemistry|April 30, 2016
High-Sensitivity Sandwich ELISA for Plasma NT-proUcn2: Plasma Concentrations and Relationship to Mortality in Heart FailureOi Wah Liew, Timothy G Yandle, Jenny P C Chong, et al.
The New Zealand Medical Journal|October 4, 2011
Prediction of cardiac rhythm 1 year following cardioversion for atrial fibrillationAmjad K Hamid, A Mark Richards, Ian G Crozier, et al.
Endocrinology|July 26, 2008
Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarctionLeigh J Ellmers, Nicola J A Scott, Satyanarayana Medicherla, et al.
Circulation|May 29, 2003
B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarctionA Mark Richards, M Gary Nicholls, Eric A Espiner, et al.
Pageof 39

Showing results (171-180 of 390) with videos related to

Sort By:
Pageof 39
Frontiers in Cardiovascular Medicine|December 11, 2020
Systemic Mesenchymal Stem Cell-Derived Exosomes Reduce Myocardial Infarct Size: Characterization With MRI in a Porcine ModelChristopher J Charles, Renee R Li, Teresa Yeung, et al.
Chest|November 2, 2013
OSA and coronary plaque characteristicsAdeline Tan, William Hau, Hee-Hwa Ho, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 8, 2010
New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosisAaron L Baggish, Roland R J van Kimmenade, Yigal Pinto, et al.
Journal of the American College of Cardiology|February 2, 2010
N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trialJohn G Lainchbury, Richard W Troughton, Kim M Strangman, et al.
Journal of Cardiac Failure|July 31, 2010
Clinical significance of endogenous vasoactive neurohormones in chronic systolic heart failureW H Wilson Tang, Kevin Shrestha, Maureen G Martin, et al.
The American Journal of Emergency Medicine|May 25, 2013
Validation of the Vancouver Chest Pain Rule using troponin as the only biomarker: a prospective cohort studyJaimi H Greenslade, Louise Cullen, Martin Than, et al.
Clinical Chemistry|April 30, 2016
High-Sensitivity Sandwich ELISA for Plasma NT-proUcn2: Plasma Concentrations and Relationship to Mortality in Heart FailureOi Wah Liew, Timothy G Yandle, Jenny P C Chong, et al.
The New Zealand Medical Journal|October 4, 2011
Prediction of cardiac rhythm 1 year following cardioversion for atrial fibrillationAmjad K Hamid, A Mark Richards, Ian G Crozier, et al.
Endocrinology|July 26, 2008
Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarctionLeigh J Ellmers, Nicola J A Scott, Satyanarayana Medicherla, et al.
Circulation|May 29, 2003
B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarctionA Mark Richards, M Gary Nicholls, Eric A Espiner, et al.
Pageof 39